Login / Signup

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.

Soichiro ShibataKenzo SakuraiKeiji TachikawaRiyoko KoSakae HinoTakayuki FukanoKenji IsahayaTakafumi HaraguchiJunji YamauchiKen-Ichiro TanabeMisako NagasakaYuta HagiwaraTakahiro ShimizuHisanao AkiyamaYasuyuki KobayashiYasuhiro HasegawaYoshihisa Yamano
Published in: Neurology international (2022)
The AI software for ASPECTS showed convincing agreement with expert evaluation and would be supportive in determining the indications of intravenous rt-PA therapy.
Keyphrases
  • high dose
  • machine learning
  • artificial intelligence
  • high throughput
  • stem cells
  • clinical practice
  • bone marrow
  • mesenchymal stem cells
  • single cell
  • replacement therapy